CHANGE IN RATINGS

Burlington Northern Santa Fe ( BNI) upgraded at Goldman to its Conviction Buy List based on valuation. Also cites best in class intermodal franchise and company is taking share from Union Pacific. Raised target price to $72 from $66.

CBS ( CBS) downgraded at UBS from Neutral to Sell. $3.80 price target. Expect lower advertising estimates through 2010. Credit rating could also be cut.

Church & Dwight ( CHD) upgraded at Oppenheimer to Outperform, Oppenheimer said. $62 price target. Company should benefit as consumers trade down toward its value-oriented portfolio.

FreeSeas ( FREE) downgraded at Credit Suisse to Neutral from Outperform based on weak freight outlook in 2009 and expectations for lower utilization for two older vessels. Lowered target price to $2 from $5.

Gap ( GPS) added to Goldman Conviction Buy List based on improving sales trends in coming months and valuation. Raised target price to $15 from $14.

Lincoln National ( LNC) downgraded at Credit Suisse to Neutral from Outperform. Cites liquidity tensions over next few months and further pressure on subsidiary capital levels. Lowered target price to $14 from $23.

Nalco Holding ( NLC) upgraded at Goldman to Buy based on better refinancing outlook and valuation -- since company trades at a 25% discount to peers. Sets 6-month target price at $16.

Potash ( POT) downgraded at Soleil to Hold from Buy based on short-term fertilizer demand destruction and longer-term lower potash prices. Lowered target price to $100.

Quality Systems ( QSII) downgraded at UBS from Neutral to Sell. $44 price target. Valuation call, as the company is likely facing a volatile year. Insider selling has also remained steady.

STOCK COMMENTS / EPS CHANGES

Allergan ( AGN) target raised at UBS to $54. Stock has moved higher on GSK takeover rumors. Maintain Buy rating, as earnings look too conservative. The pipeline also has good potential.

Credit Suisse is Deere's ( DE) 2009 and 2010 EPS estimates on DE based on weaker farm equipment demand and more cautious outlook from farmers. Lowered target price to $40 from $41.

MetLife ( MET) added to Top Picks Live list at Citigroup. Valuation call, even though estimates were cut because of lower investment income. Buy rating and new $35 price target.

Pepco ( POM) estimates, target reduced at Barclays. Shares now seen reaching $14, Barclays Capital said. Estimates also cut, to reflect the new margin guidance given at the company's analyst meeting. Equal-weight rating.

This article was written by a staff member of TheStreet.com.

More from Stocks

North Korea, Apple, GPDR and Gap - 5 Things You Must Know

North Korea, Apple, GPDR and Gap - 5 Things You Must Know

Market Can't Handle the Wild Ride: Cramer's 'Mad Money' Recap (Thursday 5/24/18)

Market Can't Handle the Wild Ride: Cramer's 'Mad Money' Recap (Thursday 5/24/18)

Replay: Jim Cramer on North Korea, Oil Prices, Apple and Carnival Corporation

Replay: Jim Cramer on North Korea, Oil Prices, Apple and Carnival Corporation

Canopy Growth: First Cannabis Firm on the NYSE Fails to Generate Buzz

Canopy Growth: First Cannabis Firm on the NYSE Fails to Generate Buzz

Video: This Startup Connects Buyers and Sellers of Legal Marijuana

Video: This Startup Connects Buyers and Sellers of Legal Marijuana